Hospital News and Research

RSS

State roundup: Genetic testing on campus, Texas docs in Mass., and more

"A plan by the University of California, Berkeley to voluntarily test the DNA of incoming freshman has come under fire from critics who said the school was pushing an unproven technology on impressionable students. The university has said it will send test kits to 5,500 new students to analyze genes that help control the body's responses to alcohol, dairy products and folic acid" (Wohlsen, 5/21).

24 May 2010

New Mexico meets all requirements for operational planning as part of ARRA state HIE program: ONC

New Mexico is the first state to meet all requirements for strategic and operational planning as part of the American Recovery and Reinvestment Act state health information exchange cooperative agreement program, according to the United States Office of the National Coordinator for Health Information Technology.

24 May 2010

Lytix Biopharma receives approval to initiate Phase I/IIa clinical trial of Lytixar for MRSA

The Norwegian pharmaceutical company Lytix Biopharma AS today announces the approval by the Swedish Medical Products Agency to commence a Phase I/IIa clinical trial with Lytixar (LTX-109) for nasal decolonisation of MRSA.

24 May 2010

New technique designed to analyze individual immune cells may help diagnose food allergies: Study

About 30 percent of Americans believe they have food allergies. However, the actual number is far smaller, closer to 5 percent, according to a recent study commissioned by the National Institute of Allergy and Infectious Diseases. That's due in large part to the unreliability of the skin test that doctors commonly use to test for food allergies.

24 May 2010

ICON announces acquisition of Timaq Medical Imaging

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has acquired Timaq Medical Imaging, a leading European provider of advanced imaging services to pharmaceutical and biotech firms.

24 May 2010

New findings on INTUNIV Extended Release Tablets presented at major psychiatric meeting

Shire plc, the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV (guanfacine) Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention Deficit Hyperactivity Disorder, at a major psychiatric meeting.

24 May 2010

Researchers develop new therapy for psychological treatment of patients suffering from fibromyalgia

Researchers of the Labpsictec at the Universitat Jaume I of Castellon and the LahHuman Group at the Universidad Politecnica of Valencia and the University of Valencia have developed a new therapy based on the use of mobile devices and virtual reality for the psychological treatment of patients suffering from fibromyalgia.

24 May 2010

SiMoA technology measures individual PSA molecules in prostate cancer patients: Nature Biotechnology

Quanterix Corporation, the single molecule diagnostics company focused on developing and commercializing high sensitivity tests, announced the publication of a breakthrough study of the company's proprietary technology that demonstrates an unprecedented sensitivity for measuring a biomarker for prostate cancer recurrence.

24 May 2010

New study indicates pregnancy can double HIV risk in men

Young women of reproductive-age are among those at greatest risk of acquiring HIV, and several studies have suggested that during pregnancy women are even more susceptible to infection.

24 May 2010

Overall proportion of hospital patients died after heart attack fell by 37%: AHRQ

The overall proportion of hospital patients who died in the hospital after a heart attack fell by 37 percent between 2000 and 2007, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. The rate fell from from 106 per 1,000 patients to 67 per 1,000 patients during the period

21 May 2010

Bristol-Myers Squibb announces positive results from Phase 2 study of ipilimumab in patients with NSCLC

Bristol-Myers Squibb Company today announced positive results from a randomized Phase 2 study evaluating ipilimumab in combination with standard chemotherapy in previously untreated patients with advanced non-small cell lung cancer.

21 May 2010

Young Faces of ALS campaign to raise awareness on ALS

The ALS Therapy Development Institute announced today that it is supporting a new awareness campaign driven by several ALS patients diagnosed with the progressive neurodegenerative disease commonly known as Lou Gehrig's disease before the age of 30. This campaign, called "Young Faces of ALS," is designed and led by a group of seven young men and women and will consist of a group effort to visit each of the 30 Major League Baseball parks during the 2010 baseball season.

21 May 2010

High family medical bills appear to reduce use of expensive medications: Study

People with rheumatoid arthritis whose health insurance requires them to pay a higher share of the cost are less likely to use biotech drugs than those with coverage that is more generous. High family medical bills also appear to reduce the use of these powerful but expensive medications, according to a new study in Health Services Research.

21 May 2010

New marker may be the significant breakthrough in allergy testing for newborn babies

A simple blood test can now predict whether newborn babies are at high risk of developing allergies as they grow older, thanks to research involving the University of Adelaide.

21 May 2010

Democrats push three-year Medicare 'doc fix' as part of larger tax bill

A proposal to stop planned payment cuts to Medicare doctors for three years is in a bill extending tax cuts and lengthening unemployment benefits.

21 May 2010

Researchers study correlation between type 2 diabetes and increased risk of cancer

Cancer and diabetes - are risk factors the same for these two diseases? Or does diabetes cause processes in the body which promote the onset or growth of cancer? It is still unclear why diabetics have a higher rate of cancer than people who are not affected by this metabolic disorder.

21 May 2010

Consumers roundup: More patients choose high-deductible plans; Many neglect doctors medication directions

"The number of Americans enrolled in high-deductible health plans has risen to more than 10 million but still represents a small portion of the insurance market, according to a report from insurance group America's Health Insurance Plans. Enrollments in these high-deductible health plans, which typically are paired with tax-free health savings accounts or health-reimbursement arrangements, are up about 25 percent from last year, the report said" (5/20).

21 May 2010

PDGFRA gene may lead to effective treatments for paediatric high grade glioma: Study

Scientists have discovered a gene that could lead to more effective treatments for a form of childhood brain cancer called paediatric high grade glioma.

21 May 2010

Researchers analyze impact of health promotion program on cardiovascular disease-related medical, hospital costs

A comprehensive health promotion program reduced cardiovascular disease-related medical and hospital costs, according to a new study. CSX Transportation, a national company with 30,000 employees, developed the program in 2004 to address employees' high rates of cardiovascular disease when compared to national benchmarks and the associated higher healthcare costs.

21 May 2010

Lack of discussion on resuming sex after heart attack associated with less sexual activity

Sexual activity declines in the year after heart attack for patients who don't get instructions from their doctors about when it's safe to resume sex, researchers reported at the American Heart Association's 11th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.

21 May 2010

Hospital News and Research

State roundup: Genetic testing on campus, Texas docs in Mass., and more

New Mexico meets all requirements for operational planning as part of ARRA state HIE program: ONC

Lytix Biopharma receives approval to initiate Phase I/IIa clinical trial of Lytixar for MRSA

New technique designed to analyze individual immune cells may help diagnose food allergies: Study

ICON announces acquisition of Timaq Medical Imaging

New findings on INTUNIV Extended Release Tablets presented at major psychiatric meeting

Researchers develop new therapy for psychological treatment of patients suffering from fibromyalgia

SiMoA technology measures individual PSA molecules in prostate cancer patients: Nature Biotechnology

New study indicates pregnancy can double HIV risk in men

Overall proportion of hospital patients died after heart attack fell by 37%: AHRQ

Bristol-Myers Squibb announces positive results from Phase 2 study of ipilimumab in patients with NSCLC

Young Faces of ALS campaign to raise awareness on ALS

High family medical bills appear to reduce use of expensive medications: Study

New marker may be the significant breakthrough in allergy testing for newborn babies

Democrats push three-year Medicare 'doc fix' as part of larger tax bill

Researchers study correlation between type 2 diabetes and increased risk of cancer

Consumers roundup: More patients choose high-deductible plans; Many neglect doctors medication directions

PDGFRA gene may lead to effective treatments for paediatric high grade glioma: Study

Researchers analyze impact of health promotion program on cardiovascular disease-related medical, hospital costs

Lack of discussion on resuming sex after heart attack associated with less sexual activity

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News